Vaccine-Manufacturing

Do you have an idea for The New Times to cover? Submit it here!
Search Results for "Vaccine-Manufacturing" (245 articles)
President Paul Kagame during a guided tour of BioNTech Facility Mainz, in Germany on March 29, 2022. The firm has secured $145m in a bid to strengthen Africa’s mRNA vaccine ecosystem. Village Urugwiro
Health

BioNTech names three “priority” areas after securing Rwf180bn funding

Tuesday, June 04, 2024
The funding will support BioNTech to establish mRNA vaccine research and development (R&D), clinical, and commercial-scale manufacturing capabilities at the company’s facility in Kigali.
Editorial

BioNTech-CEPI partnership is a shot in the arm for Rwanda’s vaccine ecosystem

Friday, May 31, 2024
President Kagame and other dignitaries officially inaugurate BioNTech’s vaccine manufacturing plant in Kigali on December 18, 2023. The plant is set for $145 million in funding. Courtesy
Health

BioNTech's vaccine plant in Rwanda gets over Rwf180bn boost

Friday, May 31, 2024
Prime Minister Edouard Ngirente delivers remarks at the 5th International Network for Governmental Science Advice Conference (INGSA) at Kigali Convention Centre in Kigali on Tuesday, April 30. Photo Courtesy
Rwanda

PM Ngirente advocates for skilled workforce to meet labour market demands

Wednesday, May 01, 2024
Dr Sabin Nsanzimana (R), the Rwandan Minister of Health, and Minata Samate Cessouma, the AU Commissioner for Health, Humanitarian Affairs, and Social Development, shake hands after signing a host agreement for the African Medicines Agency (AMA) in Kigali in June 2023. Photo by Olivier Mugwiza

Rwanda hosting AMA headquarters could be a game-changer for health in Africa

Tuesday, April 23, 2024
ials labelled "VACCINE Coronavirus COVID-19" and a syringe are seen in front of a displayed Moderna logo in this illustration taken December 11, 2021. REUTERS/Dado Ruvic
Africa

Moderna pauses plans to build vaccines facility in Kenya

Friday, April 12, 2024
President Paul Kagame, with several heads of state and government, and other senior delegates including BioNTech founder and CEO Ugur Sahin (3rd-L) offically launch BioNTech’s mRNA vaccine manufacturing plant in Kigali on December 18, 2023.

Rwanda's path to pharma self-sufficiency: Strengthening regulatory oversight and building a robust healthcare system

Tuesday, April 09, 2024
Experts said that the growing workforce needs in vaccine manufacturing and expressed optimism about the Master of Vaccinology course, for addressing this gap.
Editorial

UR’s new vaccinology programme is a step in the right direction

Monday, March 11, 2024
Experts discuss on the potential of these programmes to address current challenges during a validation workshop for the courses on March 7. All Photos by Craish Bahizi
Featured

UR to launch Master’s programmes for vaccine manufacturing advancement

Sunday, March 10, 2024
Kagame with other dignitaries during the launch of Africa's first mRNA technology vaccine manufacturing plant – BioNTech in Kigali. OLIVIER MUGWIZA
Editorial

As Rwanda's pharma industry takes off, training should respond to reality

Friday, March 01, 2024
The New Times
Health

Rwanda to host Africa global vaccine institute office

Tuesday, February 27, 2024
Minister of State for Health, Yvan Butera, delivers remarks during a panel discussion at the AU Summit on February 17. Courtesy  
Health

It is important to scale up vaccine production in Africa — Minister Butera

Tuesday, February 20, 2024